Skip to content

ShroomsMedicine

Instagram

Home
Shop
Contact
Experience
Blog

Healing with Magic Mushrooms

Explore the Science of Psilocybin for Mental Wellness and Healing.

Albino Penis Envy (APE)

Several mushrooms with light brown caps and white stems grow in a lush, green grass field under a bright blue sky. The perspective is low to the ground, emphasizing the mushrooms' gills and natural surroundings.

Experience unmatched potency.

Albino APE

A solitary mushroom is growing in a lush, green forest environment, surrounded by vibrant moss and blurred, bokeh-like tree backgrounds creating a serene and natural setting.

Transformative psychedelic journey.

Psychedelic Trip

APE Power

Product on sale

Albino Peni Envy (APE) 0.15g – 150mg x 30 Pills

Original price was: $50.00.Current price is: $40.00.
Product on sale

Albino Peni Envy (APE) 0.3g – 300mg x 10 Pills

Original price was: $40.00.Current price is: $30.00.

shroomsmedicine

🌿 Free spirit traveling life
✨ Mystic experience turned holistic biz owner 🔮
🐾 Animal lover | Living untamed & free 💫
💕 Expand with me

BREAKTHROUGH: SCIENTISTS FINALLY SEE HOW PSILOCYBI

BREAKTHROUGH: SCIENTISTS FINALLY SEE HOW PSILOCYBIN "REWIRES" THE DEPRESSED BRAIN 🧠🍄

New neuroimaging research from Imperial College London is revealing the biological blueprint behind psilocybin’s lasting antidepressant effects—and it’s changing everything we know about recovery.

🔬 Using advanced PET and fMRI scanning, researchers tracked patients with treatment-resistant depression through psilocybin-assisted therapy. What they found was remarkable: a physical restoration of synaptic connectivity and a reboot of Default Mode Network flexibility, the very brain circuits that become rigid and isolated during chronic depression.

💊 Unlike daily medications that merely manage symptoms, psilocybin appears to actively rebuild neural architecture. Patients showed measurable structural improvements and reduced rumination patterns that persisted up to six months after only one or two sessions.

🌍 This study provides the strongest mechanistic evidence to date for why psychedelic therapy can produce profound, durable change. As regulatory pathways accelerate, science is finally catching up to what indigenous healers have known for centuries.

The future of psychiatry isn’t just chemical—it’s structural. 💡

#Psilocybin #PsychedelicResearch #MentalHealth #Neuroplasticity

We’re so used to rushing that stillness feels fore

We’re so used to rushing that stillness feels foreign. But the body remembers — it knows how to soften, how to breathe, how to be. Today’s ritual: hot tea, golden light, and giving myself permission to do absolutely nothing. 🍵🌿🍄

COLORADO'S PSILOCYBIN REPORT IS HERE—AND THE NUMBE

COLORADO'S PSILOCYBIN REPORT IS HERE—AND THE NUMBERS ARE STUNNING 📊🍄

FDA PANEL TO VOTE ON PSILOCYBIN THERAPY THIS WEEK

FDA PANEL TO VOTE ON PSILOCYBIN THERAPY THIS WEEK — A HISTORIC MOMENT FOR MENTAL HEALTH 🍄⚖️

BREAKTHROUGH: PSILOCYBIN OFFERS NEW HOPE FOR ANORE

BREAKTHROUGH: PSILOCYBIN OFFERS NEW HOPE FOR ANOREXIA TREATMENT 🍄⚡

Why microdosing mushrooms is everywhere right now

Why microdosing mushrooms is everywhere right now

Sacred mornings start with intention 🍄✨ Whether it

Sacred mornings start with intention 🍄✨ Whether it's a microdose, a meditation, or just a deep breath — how are you showing up for yourself today?

MDMA THERAPY SAVED THIS MOTHER'S LIFE AFTER THE UN

MDMA THERAPY SAVED THIS MOTHER'S LIFE AFTER THE UNIMAGINABLE 💔🍄

An Australian mother who tragically lost her 3-year-old daughter credits MDMA-assisted therapy with saving her life, in a powerful new feature from the Australian Broadcasting Corporation published May 28, 2026

#PsychedelicTherapy #MentalHealth #TraumaHealing #Psilocybin

A little trip down memory lane. #travel #newyork

A little trip down memory lane.
#travel #newyork

BREAKING: NEW YORK BECOMES THIRD STATE TO LEGALIZE

BREAKING: NEW YORK BECOMES THIRD STATE TO LEGALIZE PSILOCYBIN THERAPY 🍄📜

New York lawmakers pass legislation establishing a state-regulated psilocybin therapy program for adults 21+, becoming the third U.S. state to create a licensed framework for legal psychedelic-assisted services.

#Psilocybin #PsychedelicNews #MentalHealth #DrugPolicyReform

Rituals that set the tone 🌿✨ Journaling + lion's

Rituals that set the tone 🌿✨

Journaling + lion's mane = my recipe for a focused, productive day. There's something magical about slow afternoons—letting the sunlight in, sipping something warm, and putting pen to paper. ☕📝

What does your afternoon routine look like? Tell me below 👇

#productivity #lionsmane #wellness #selfcare #mindfulness #journaling #cozyvibes #lifestyle

An easy morning routine makes all the difference!

An easy morning routine makes all the difference! ☀️ #Morning #Routine #Difference

This morning, let's wake up and give thanks! 🙏😊 #M

This morning, let's wake up and give thanks! 🙏😊 #Morning #gratitude

It’s okay to not be okay… but it’s NOT okay to g

It’s okay to not be okay... but it’s NOT okay to give up. You’ve survived one hundred percent of your hardest days—so keep going... because you are so much STRONGER than you think.

Morning tea 🍵

PSILOCYBIN IS ONE STEP AWAY FROM FDA APPROVAL 🍄💊

PSILOCYBIN IS ONE STEP AWAY FROM FDA APPROVAL 🍄💊

Compass Pathways just announced game-changing Phase 3 results for COMP360 — a synthetic psilocybin treatment for depression that doesn't respond to traditional meds.

Here's what happened:
→ 39% of patients saw clinically meaningful improvement at 6 weeks
→ Effects started literally THE DAY AFTER taking it
→ Two successful Phase 3 trials back-to-back (that's 3-for-3 if you count Phase 2)

The company is now preparing to submit its FDA application by the end of this year. If approved, this would be the FIRST classic psychedelic medicine cleared for the U.S. market.

Treatment-resistant depression affects 4 million Americans. Current options are limited. This could be the breakthrough they've been waiting for.

The UK and Germany aren't far behind — both are already preparing regulatory pathways.

Science is moving fast. The psychedelic renaissance is becoming the psychedelic reality.

What do you think — are you ready for FDA-approved psilocybin therapy?

#Psilocybin #PsychedelicResearch #MentalHealth #COMP360

🧠 One dose. Lasting brain changes. Scientists just

🧠 One dose. Lasting brain changes. Scientists just found something remarkable.

A new study from Imperial College London — published in Nature Communications — reveals that a single dose of psilocybin can cause anatomical changes in the brain that are still visible a month later.

Researchers used advanced brain scans (DTI) on 28 first-time participants and found that nerve tracts became denser and more robust after one 25mg dose. The opposite pattern is seen in ageing and dementia.

Here's the wild part: the people whose brains showed the most "flexibility" during the experience reported the deepest insights and best wellbeing a full month afterward.

This isn't just about feeling better in the moment. It's physical evidence that psilocybin may literally rewire the brain — supporting why research suggests it could help with depression, anxiety, and addiction.

Prof Robin Carhart-Harris (UCSF): "It's remarkable to see potential anatomical brain changes one month after a single dose of any drug."

The science is catching up to what indigenous cultures have known for centuries. 🍄

What do you think — does this change how you view psychedelic research?

Drop a 🧠 if you're following the science.

—

⚠️ This is educational content about published research. Not medical advice. Psilocybin remains illegal in many jurisdictions. Always follow local laws.

#psilocybin #magicmushrooms #brainscience #neuroscience #psychedelicresearch mentalhealth depression anxiety addiction naturecommunications imperialcollege robin-carhart-harris neuroplasticity psychedelicscience shrooms mushrooms consciousness brainhealth science

───

Also notable today:
• Compass Pathways confirmed Q4 FDA filing on track for COMP360 (treatment-resistant depression) — 40% response rate, 6-month durability
• FDA fast-tracking psilocybin with National Priority Vouchers; potential approvals summer/fall 2026
• New OCD trial: 73% response rate, 40% full remission at 6 months

🧠 ONE DOSE. LASTING BRAIN CHANGES. A new study fr

🧠 ONE DOSE. LASTING BRAIN CHANGES.

A new study from UCSF & Imperial College London — published in Nature Communications — just revealed something remarkable:

A single dose of psilocybin can cause anatomical changes in the brain that are still detectable a MONTH later.

Here's what happened:

→ 28 people who had never taken psychedelics before received one 25mg dose
→ Brain scans showed changes in nerve tract density 30 days later
→ During the experience, their brains showed a surge in "entropy" — basically, the brain processing way more diverse information than usual
→ The people with the biggest entropy spikes? They reported the deepest insights and best wellbeing a month out

The wild part: these changes are the opposite of what scientists see in aging and dementia.

This matters because it gives us a real biological mechanism for why psilocybin therapy seems to help with depression, anxiety, and addiction. It's not just the trip — something actually shifts in the brain's wiring.

This was an early study (small group, healthy volunteers), so more research is needed. But it's a huge step toward understanding HOW these compounds work.

Science is catching up to what indigenous cultures have known for thousands of years 🍄

What's one question you have about psilocybin research? Drop it below 👇

───

Sources:
• Nature Communications (study): https://www.nature.com/articles/s41467-026-71962-3
• The Guardian coverage: https://www.theguardian.com/science/2026/may/05/magic-mushrooms-psychedelic-changes-brain-anatomy-psilocybin
• Medical News Today: https://www.medicalnewstoday.com/articles/one-dose-psilocybin-reshape-brain-activity-support-mental-health-study-neuroplasticity

🍄 ONE DOSE. 53% REMISSION. Here's what just happen

🍄 ONE DOSE. 53% REMISSION. Here's what just happened in Sweden.

A new Phase 2 trial from Karolinska Institutet (published in JAMA Network Open) found that a single 25mg dose of psilocybin — combined with therapy — led to full depression remission in 53% of participants at 6 weeks. The control group? Just 6%.

Even more striking: the antidepressant effect showed up within 2 DAYS. Compare that to SSRIs, which often take 4–6 weeks to kick in.

This wasn't treatment-resistant or cancer-related depression either. It was common, recurrent depression — the kind millions of people live with. That's what makes this study different from most psilocybin research so far.

Scientists still caution that larger trials are needed, and the "blinding problem" in psychedelic studies remains a real challenge (participants often know if they got the real thing). But the signal is getting harder to ignore.

Research suggests psilocybin may help the brain break out of rigid, repetitive thought patterns — something depression is notorious for locking people into.

The psychedelic renaissance isn't hype anymore. It's data.

What study are you most excited to see next? Drop it below 👇

—

#psilocybin #magicmushrooms #depression #mentalhealth #psychedelicscience psychedelicresearch karolinskainstitutet jama clinicaltrials psychedelictherapy neuroscience mentalhealthawareness shrooms psychedelics

Instagram post 18096232790266274

Instagram post 18096232790266274

Follow on Instagram

Menu

Home
Shop
Contact
Experience
Blog

Contacts

contact@shroomsmedicine.org

Instagram

Session Messenger ID

05ccec9befa8d36d1f8a6bedea057a278ce4ca8600afa349d5bd0bda07d6d6041d

© 2026 ShroomsMedicine. All rights reserved.

Your cart (items: 0)

Products in cart
Product	Details	Total
	Available on backorder Previous price: Discounted price:	Save

Subtotal $0.00

Shipping calculated at checkout.

Your cart is currently empty!

Notifications